Developers-Doctor-patients: the artificial intelligence’s trifecta
Longitudinal change in castration-resistant prostate cancer biomarker AST/ALT ratio reflects tumor progression
Evolution of structural rearrangements in prostate cancer intracranial metastases
Changes in the gut microbial profile during long-term androgen deprivation therapy for prostate cancer
The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapy
© 2023 Altruu.
Post was successfully added to your altruuline!
You have reached your limit of 250000 buddies! We proud of you!
Size Exceeds: The file exceeds allowed the limit (46 MB) and cannot be uploaded
File type is not supported, unable to upload